🔎 Trials Near Me

Beranda › Kanker Gastrointestinal › New York › New York City

Uji klinis Kanker Gastrointestinal di New York City, NY

12 studi untuk Kanker Gastrointestinal mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Menerima pesertaFase 3
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07218926

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Menerima pesertaFase 3
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07222800

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Menerima pesertaFase 1/2
  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering Cancer Center Main Campus, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Menerima pesertaFase 1/2
  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Menerima peserta
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05837767

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Menerima pesertaFase 1
  • New York Cancer & Blood Specialists, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT06582017

A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05789485

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

Menerima pesertaFase 1/2
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06885034

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Menerima pesertaFase 1
  • NYU Langone, New York
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT06040541

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Menerima pesertaFase 1/2
  • Perlmutter Cancer Center at NYU Langone Health, New York
  • Memorial Sloan-Kettering Cancer Center, New York
  • Columbia University, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT05379985

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Menerima pesertaFase 1/2
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Apr 2026 · NCT07020221

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

Menerima peserta
  • The New York Proton Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT05313191

Uji klinis Kanker Gastrointestinal di kota lain

Studi lain di New York City

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.